EIF4A2 and acute myeloid leukemia: Thus, understanding the functional role of the EIF4A2-specific RNA targets in AML and LSC may provide mechanistic support for specifically targeting EIF4A2 and/or its regulated pathways for AML treatment and directing the improvement of drug target sensitivity.